The role of l-thyroxine and hepatic reductase activity in isoniazid-induced hepatotoxicity in rabbits

Pharmacol Res. 1998 Sep;38(3):199-207. doi: 10.1006/phrs.1998.0347.

Abstract

There is evidence that hydrazine, a metabolite of isoniazid, plays an important role in the mechanism of isoniazid-induced hepatotoxicity. Hydrazine has been reported to be metabolised by NADPH cytochrome P-450 reductase (reductase) to reactive and potentially toxic intermediates. The present study was designed, using a model of isoniazid-induced hepatotoxicity in rabbits, to determine whether or not reductase plays a role in this toxicity. Although pretreating rabbits with l-thyroxine increased hepatic reductase activity (54% greater than controls), the severity of isoniazid-induced hepatic cell damage (plasma argininosuccinic acid lyase activity) was lower in thyroxine pre-treated animals than in animals treated with isoniazid alone (31.3+/-20 vs 56.0+/-20 Takahara Units, respectively). In addition, pre-treatment with l-thyroxine completely prevented isoniazid-induced hepatic steatosis. In conclusion, contrary to our hypothesis, an increase in reductase activity achieved by pre-treatment with l-thyroxine was associated with a decrease in the severity of isoniazid-induced hepatic cell damage and steatosis in rabbits.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antitubercular Agents / toxicity*
  • Cytochrome P-450 CYP2E1 / metabolism
  • Hydrazines / toxicity
  • Isoniazid / metabolism
  • Isoniazid / toxicity*
  • Liver / drug effects*
  • Liver / enzymology
  • Male
  • Methimazole / pharmacology
  • NADPH-Ferrihemoprotein Reductase / metabolism*
  • Rabbits
  • Thyroxine / pharmacology*

Substances

  • Antitubercular Agents
  • Hydrazines
  • hydrazine
  • Methimazole
  • Cytochrome P-450 CYP2E1
  • NADPH-Ferrihemoprotein Reductase
  • Thyroxine
  • Isoniazid